Literature DB >> 1090535

Opsonin-reversible resistance of Mycoplasma pneumoniae to in vitro phagocytosis by alveolar macrophages.

D A Powell, W A Clyde.   

Abstract

Several species of mycoplasmas are responsible for respiratory disease in animals and man. As yet, little is known about the interaction of these pathogens with alveolar macrophages, one of the primary components of pulmonary resistance to infections. The present study was undertaken to develop an in vitro model to examine this organism-cell interaction, using a human pathogen, mycoplasma pneumoniae, and normal guinea pig alveolar macrophages. During a 24-h incubation of M. pneumoniae with a monolayer of macrophages, mycoplasmas were found to attach directly to the surface of the cells without inducing significant phagocytosis. Ultrastructurally, the organisms appeared bound to the cell membrane by their characteristic attachment organelles. Only after the addition of specific anti-mycoplasma serum were cells able to engulf attached and surrounding organisms. These data suggest that the interaction of M. pneumoniae and alveolar macrophages is a potentially important aspect of disease pathogenesis, and immune factors which might alter this interaction merit further examination.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090535      PMCID: PMC415099          DOI: 10.1128/iai.11.3.540-550.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers.

Authors:  H Brunner; H B Greenberg; W D James; R L Horswood; R B Couch; R M Chanock
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

2.  Immunoglobulin-containing cells in lungs of hamsters infected with Mycoplasma pneumoniae.

Authors:  G W Fernald; W A Clyde; J Bienenstock
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

3.  Appearance of Mycoplasma pneumoniae in lungs of experimentally infected hamsters and sputum from patients with natural disease.

Authors:  A M Collier; W A Clyde
Journal:  Am Rev Respir Dis       Date:  1974-12

4.  Function of the alveolar macrophage in immunity.

Authors:  Q N Myrvik
Journal:  J Reticuloendothel Soc       Date:  1972-05

5.  Antibodies in bronchial secretions following natural infection with Mycoplasma pneumoniae.

Authors:  G Biberfeld; G Sterner
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

6.  The interaction in vitro between polymorphonuclear leukocytes and mycoplasma.

Authors:  M S Simberkoff; P Elsbach
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307

7.  Immune enhancement of pulmonary bactericidal activity in murine virus pneumonia.

Authors:  G J Jakab; G M Green
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Relationships Between Mycoplasma pneumoniae and Human Respiratory Epithelium.

Authors:  A M Collier; W A Clyde
Journal:  Infect Immun       Date:  1971-05       Impact factor: 3.441

9.  THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG.

Authors:  G M GREEN; E H KASS
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

10.  The interaction of mycoplasmas with mammalian cells. I. HeLa cells, neutrophils, and eosinophils.

Authors:  D Zucker-Franklin; M Davidson; L Thomas
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  16 in total

1.  Interaction of Mycoplasma pneumoniae with alveolar macrophages: viability of adherent and ingested mycoplasmas.

Authors:  P Erb; W Bredt
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Phagocytosis by macrophages of mycoplasma pneumoniae after opsonization by complement.

Authors:  W Bredt
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

3.  Demonstration of multiple antigenic determinants on Mycoplasma pneumoniae attachment protein by monoclonal antibodies.

Authors:  P C Hu; C H Huang; Y S Huang; A M Collier; W A Clyde
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

4.  Release of Mycoplasma pneumoniae substances after phagocytosis by guinea pig alveolar macrophages.

Authors:  M Kist; E Jacobs; W Bredt
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

Review 5.  Microbial surfaces in relation to pathogenicity.

Authors:  H Smith
Journal:  Bacteriol Rev       Date:  1977-06

6.  Ciliated respiratory epithelial monolayers: new model for Mycoplasma pneumoniae infection.

Authors:  M G Gabridge; H Gunderson; S L Schaeffer; Y D Barden-Stahl
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

7.  Effect of corynebacterium parvum in the induction and course of mycoplasma arthritis of mice.

Authors:  E Kaklamani; P Kaklamanis; L Sparos; D Karalis; K Alikouli; I Koumandaki; D Trichopoulos
Journal:  Clin Rheumatol       Date:  1983-06       Impact factor: 2.980

Review 8.  Pathogenicity factors of mycoplasmas.

Authors:  W Bredt
Journal:  Infection       Date:  1976       Impact factor: 3.553

9.  Antigenic determinants of the attachment protein of Mycoplasma pneumoniae shared by other pathogenic Mycoplasma species.

Authors:  W A Clyde; P C Hu
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

10.  Interaction of Mycoplasma dispar and Mycoplasma agalactiae subsp. bovis with bovine alveolar macrophages and bovine lacteal polymorphonuclear leukocytes.

Authors:  C J Howard; G Taylor; J Collins; R N Gourlay
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.